It looked like a recipe for disaster. So, when his country's swimmers were being accused of doping earlier this year, one Chinese official cooked up something fast. He blamed it on contaminated noodles. In fact, he argued, it could have been a culinary conspiracy concocted by criminals, whose actions led to the cooking wine used to prepare the noodles being laced with a banned heart drug that found its way into an athlete's system. This theory was spelled out to international anti-doping officials during a meeting and, after weeks of wrangling, finally made it into the thousands of pages of data handed over to the lawyer who investigated the case involving 23 Chinese swimmers who had tested positive for that same drug. The attorney, appointed by the World Anti-Doping Agency, refused to consider that scenario as he sifted through the evidence. In spelling out his reasoning, lawyer Eric Cottier paid heed to the half-baked nature of the theory. "The Investigator considers this scenario, which he has described in the conditional tense, to be possible, no less, no more," Cottier wrote. Even without the contaminated-noodles theory, Cottier found problems with the way WADA and the Chinese handled the case but ultimately determined WADA had acted reasonably in not appealing China's conclusion that its athletes had been inadvertently contaminated. Critics of the way the China case was handled can't help but wonder if a wider exploration of the noodle theory, details of which were discovered by The Associated Press via notes and emails from after the meeting where it was delivered, might have lent a different flavor to Cottier's conclusions. "There are more story twists to the ways the Chinese explain the TMZ case than a James Bond movie," said Rob Koehler, the director general of the advocacy group Global Athlete. "And all of it is complete fiction." In April, reporting from the New York Times and the German broadcaster ARD revealed that the 23 Chinese swimmers had tested positive for the banned heart medication trimetazidine, also known as TMZ. China's anti-doping agency determined the athletes had been contaminated, and so, did not sanction them. WADA accepted that explanation, did not press the case further, and China was never made to deliver a public notice about the "no-fault findings," as is often seen in similar cases. The stock explanation for the contamination was that traces of TMZ were found in the kitchen of a hotel where the swimmers were staying. In his 58-page report, Cottier relayed some suspicions about the feasibility of that chain of events — noting that WADA's chief scientist "saw no other solution than to accept it, even if he continued to have doubts about the reality of contamination as described by the Chinese authorities." But without evidence to support pursuing the case, and with the chance of winning an appeal at almost nil, Cottier determined WADA's "decision not to appeal appears indisputably reasonable." A mystery remained: How did those traces of TMZ get into the kitchen? Shortly after the doping positives were revealed, the Institute of National Anti-Doping Organizations held a meeting on April 30 where it heard from the leader of China's agency, Li Zhiquan. Li's presentation was mostly filled with the same talking points that have been delivered throughout the saga — that the positive tests resulted from contamination from the kitchen. But he expanded on one way the kitchen might have become contaminated, harkening to another case in China involving a low-level TMZ positive. A pharmaceutical factory, he explained, had used industrial alcohol in the distillation process for producing TMZ. The industrial alcohol laced with the drug "then entered the market through illegal channels," he said. The alcohol "was re-used by the perpetrators to process and produce cooking wine, which is an important seasoning used locally to make beef noodles," Li said. "The contaminated beef noodles were consumed by that athlete, resulting in an extremely low concentration of TMZ in the positive sample. "The wrongdoers involved have been brought to justice." This new information raised eyebrows among the anti-doping leaders listening to Li's report. So much so that over the next month, several emails ensued to make sure the details about the noodles and wine made their way to WADA lawyers, who could then pass it onto Cottier. Eventually, Li did pass on the information to WADA general counsel Ross Wenzel and, just to be sure, one of the anti-doping leaders forwarded it, as well, according to the emails seen by the AP. All this came with Li's request that the noodles story be kept confidential. Turns out, it made it into Cottier's report, though he took the information with a grain of salt. "Indeed, giving it more attention would have required it to be documented, then scientifically verified and validated," he wrote. Neither Wenzel nor officials at the Chinese anti-doping agency returned messages from AP asking about the noodles conspiracy and the other athlete who Li suggested had been contaminated by them. Meanwhile, 11 of the swimmers who originally tested positive competed at the Paris Games earlier this year in a meet held under the cloud of the Chinese doping case. Though WADA considers the case closed, Koehler and others point to situations like this as one of many reasons that an investigation by someone other than Cottier, who was hired by WADA, is still needed. "It gives the appearance that people are just making things up as they go along on this, and hoping the story just goes away," Koehler said. "Which clearly it has not." Get local news delivered to your inbox!Fintech Mastery: How Lohith Paripati Is Revolutionizing Revenue Platforms
Should AI be used to resurrect extinct species like the Neanderthal? | Mohammad HosseiniFormer UFC champion Eddie Alvarez has revealed why Conor McGregor will struggle to escape his UFC contract. McGregor hasn’t fought in the UFC since 2021 when he broke his leg against Dustin Poirier in their trilogy bout. He became the first fighter in Dana White’s promotion to hold two belts simultaneously after knocking out Alvarez eight years ago at UFC 205. Since dropping his lightweight title to McGregor, Alvarez has left the UFC and debuted for ONE Championship. Now, he’s working with the Irishman once again as a star of the Bare Knuckle Fighting Championship (BKFC). “Realistically, I think he still has two fights left on his UFC contract,” Alvarez told MMA Fighting on Wednesday. “I just know how difficult it is, especially when you’re that valuable to a company. “I haven’t been as valuable as Conor, but back when I was basically Bellator’s main guy, I know how difficult it is to get out of those contracts. “They don’t make it easy.” Alvarez makes his third appearance under the BKFC banner against Jeremy Stephens at KnuckleMania 5 in January 2025. McGregor has also reportedly been exploring a move into the bare-knuckle promotion that he became a part-owner of in April. However, the former two-division UFC champion announced this month on social media that he was in talks with YouTuber-turned-WWE star Logan Paul for an exhibition boxing contest. He posted on X: “I am in preliminary agreements with the Ambrani family to face Logan Paul in a boxing exhibition in India. "I have agreed. I will then seek my return to the Octagon." Just two hours after his claim, Jake Paul — Logan’s younger brother, who fought Mike Tyson in November — respoded by stating McGregor had initially contacted him over a possible meeting. He said: "Now it all makes sense why Conor McGregor and his management team have been desperately trying to get MVP to negotiate for a fight between us. "As we told them privately and I’m now saying it publicly... "The only way we’re willing to explore me vs Conor in a pro boxing/MMA fight is if Dana White/UFC are at the table directly or make it clear they are okay with discussions. "Conor is washed. Needs the Paul’s. Logan [to win] by however he wants." Jake and White have gone back and forth in a bitter feud now in recent years and the UFC President has previously declared he would never work with him or his brother. This leaves McGregor in a sticky situation, as he would have to get permission from his boss White to compete against either Paul brother in a boxing bout, just like when he fought Floyd Mayweather . Speaking on McGregor’s potential endeavours into BKFC, Alvarez admitted that a move is unlikely to take place. “For him, making the company hundreds of millions of dollars, I don’t think it’s going to be an easy exit,” he said. “I think he still has two more fights with the UFC, and I’m not sure how old Conor is, but he’s not getting any younger. “It’s going to be tough for him to fight those fights out and move onto another contract. “So realistically, I don’t know if he could fight BKFC, and if he does, it’ll be maybe when he’s older.”
The first-generation BMW 2 Series Gran Coupe was arguably the second-worst thing to come out of the year 2020. It was BMW’s first front-wheel-drive car ever sold in the United States, and everything from its styling to its driving experience was viciously criticized by the press. Fast forward to the present, and we’ve learned how to navigate life with the horrors brought upon us by that wretched year. Now BMW has unveiled the second-generation 2 Series Gran Coupe . Is it going to be the vaccine that cures the ills of the first-generation car, or is it just a new variant? I got to sample the new car very briefly at BMW Test Fest this year , and initial impressions are good. Full Disclosure: BMW flew me out to its facilities in South Carolina for the annual BMW Test Fest event. I sampled upcoming tech and drove several models, but I was only given about five minutes on a closed course in the new 2 Series Gran Coupe. This isn’t a full review or even a first drive story; it’s more of a preview of a first drive. We will let you know as soon as we get more time with it. I drove a 2025 BMW M235i xDrive Gran Coupe for five minutes on a closed course at BMW’s test track in South Carolina, and from those five minutes I could tell the new car is a more cohesive vehicle than the first-gen model. When performing a few high-speed lane changes and long fast turns the M235i was stable, solid and responsive. It felt playful, and mercifully it didn’t understeer into oblivion; if anything it was more eager to oversteer. The new interior is slightly more upscale than the outgoing car’s, and it feels more spacious. One of the biggest demerits against the first-gen 2 Series Gran Coupe was its frumpy styling. The new car isn’t what I’d call a looker, but it is an improvement, especially at the rear. The new design better masks the platform’s front-wheel-drive roots, with a slightly lower nose and more flattering body lines that feel more cohesive than before. The silhouette is aided by a more graceful slope to the C-pillar, and an ass-end that looks less like a swollen forehead over awkward creased design elements. Overall it’s more closely related to the rest of the BMW lineup. All new 2 Series Gran Coupes will come standard with an M Sport exterior design package to keep the theme sporty and elevated, where the previous design’s base trim looked more like an economy car than a luxury car. Dimensions remain mostly the same as before, though it’s grown an inch in height and just under an inch in length. Beyond improving the looks, BMW gave most models more power, too. The base 228i now comes with a turbocharged 2-liter Miller cycle inline-4 that produces 241 horsepower and 295 pound-feet of torque, which is up 13 horses and 37 torques when compared to the first-gen car. The M235i also has a two-liter turbocharged four-cylinder engine, but with 312 horsepower and 295 pound-feet of torque, up 11 horsepower and actually down 37 pound-feet of torque versus the previous model. Both engines are mated to a 7-speed dual-clutch automatic transmission. BMW claims the 228i now goes from 0 to 60 mph in 5.8 seconds, 0.2 second faster than before, while the M235i takes the same claimed 4.7 seconds as the outgoing car. Of course the tech quotient is up, with the 2 Series now featuring BMW’s latest curved driver’s display and infotainment screen running the newest version of BMW iDrive. New standard features for all 2 Series Gran Coupe models include a 12-speaker Harmon/Kardon stereo, keyless entry, wireless charging, phone-as-key technology, adaptive suspension, automatic emergency braking, blind spot monitoring, a parking assistant, and adaptive cruise control with lane-keeping assist. M235i models get a standard M Sport Brake package that features four-piston front calipers developed for full-fat M models, a package that’s optional on the 228i. Most new 2 Series Gran Coupes will start going on sale in March, though base front-wheel-drive 228i models will arrive a few months later. Prices for that base FWD 228i will start at $40,775 including the $1,175 destination charge. Adding xDrive brings the price up to $42,775, while the top-of-the-line M235i xDrive starts at a pricey $50,675 before options. The second-generation BMW 2 Series Gran Coupe is an improvement over the outgoing car, but is it going to light driving enthusiast’s hearts on fire? Not likely. It is a solid entry-level luxury car with a reinvigorated sporty edge, and new looks that do a good job of righting the wrongs of its predecessor. If I was in the market for a new 2 Series Gran Coupe, though, I would much rather buy a used 3 Series if I really needed four doors, or I’d buy a proper rear-wheel-drive 2 Series coupe.In his year-end message, Tata Group Chairman N Chandrasekaran delivered a powerful reflection on the events of 2024, paying tribute to the late Ratan Tata and outlining the Group’s ambitious vision for 2025. Acknowledging the geopolitical upheavals of 2024, including ongoing conflicts in Ukraine, Gaza, and Sudan, Chandrasekaran highlighted the global shift from efficiency to resilience in supply chains. He emphasized how these changes position India for growth, given its talent pool and manufacturing potential. Chandrasekaran paid a heartfelt tribute to Ratan Tata, whose passing earlier this year left an indelible mark on the Group and India Inc. “Our Group has lost an irreplaceable role model and leader. And I have lost a cherished mentor and friend,” he wrote. Reflecting on the tributes received worldwide, he remarked, “There isn’t room in this letter to capture fully what he meant to us.” The chairman revealed Tata Group’s plans to create 500,000 new jobs in manufacturing over the next five years. These positions will span key sectors such as semiconductors, electric vehicles, solar equipment, and other critical hardware industries. “These will come in part from the aforementioned investments in facilities across India—factories and projects that will produce batteries, semiconductors, electric vehicles, solar equipment and other critical hardware destined to play a central role in the economy of tomorrow,” he shared. In addition to manufacturing, the Group anticipates significant job creation in retail, technology services, aviation, and hospitality. Chandrasekaran also highlighted recent strides in high-tech industries, including the opening of India’s first semiconductor fab in Gujarat, a new battery cell manufacturing plant in the UK, and other facilities. "Big strategic bets, made with his encouragement, are bearing fruit, particularly in hi-tech industries and manufacturing where our footprint continues to expand," he noted. Reflecting on technology's transformative power, Chandrasekaran focused on the growing role of Artificial Intelligence in healthcare and mobility. “A fundamental reversal is taking place,” he stated, explaining how advancements in technology are now driving scientific discoveries, revolutionizing industries, and improving human well-being. Looking ahead to 2025, Chandrasekaran expressed optimism for India’s economic growth, driven by the expansion of manufacturing and the digital revolution. "India’s economy is strong, and the great trends of the age are in our favor," he wrote, concluding the letter on a hopeful note.Saquon Barkley is the NFL's version of Shohei Ohtani: Analysis
Former Argentine Ambassador to Venezuela accused of treasonBusiness Briefcase: Whitehall internet project, Headwaters news, water judge candidates
( MENAFN - Investor Brand Network) Cyngn (NASDAQ: CYN) , a developer of AI-powered autonomous driving software solutions for industrial applications, has announced the closing of a follow-on offering, priced at the market, with gross proceeds to the company of approximately $20.0 million. The transaction closed on Dec. 23, 2024. Cyngn intends to use the net proceeds from the offering, together with its existing cash, for general corporate purposes and working capital. Aegis Capital Corp. acted as exclusive placement agent for the offering. Sichenzia Ross Ference Carmel LLP acted as counsel to the company, and Kaufman & Canoles, P.C. acted as counsel to Aegis. To view the full press release, visit About Cyngn Inc. Cyngn develops and deploys scalable, differentiated autonomous vehicle technology for industrial organizations. Cyngn's self-driving solutions allow existing workforces to increase productivity and efficiency. The company addresses significant challenges facing industrial organizations today, such as labor shortages, costly safety incidents, and increased consumer demand for eCommerce. Cyngn's DriveMod Kit can be installed on new industrial vehicles at end of line or via retrofit, empowering customers to seamlessly adopt self-driving technology into their operations without high upfront costs or the need to completely replace existing vehicle investments. Cyngn's flagship product, its Enterprise Autonomy Suite, includes DriveMod (autonomous vehicle system), Cyngn Insight (customer-facing suite of AV fleet management, teleoperation, and analytics tools), and Cyngn Evolve (internal toolkit that enables Cyngn to leverage data from the field for artificial intelligence, simulation and modeling). About TechMediaWire TechMediaWire (“TMW”) is a specialized communications platform with a focus on pioneering public and private companies driving the future of technology. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers : (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries ; (2) article and editorial syndication to 5,000+ outlets ; (3) enhanced press release enhancement to ensure maximum impact ; (4) social media distribution via IBN to millions of social media followers ; and (5) a full array of tailored corporate communications solutions . With broad reach and a seasoned team of contributing journalists and writers, TMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists, and the general public. By cutting through the overload of information in today's market, TMW brings its clients unparalleled recognition and brand awareness. TMW is where breaking news, insightful content and actionable information converge. To receive SMS alerts from TechMediaWire, text“TECH” to 888-902-4192 (U.S. Mobile Phones Only) For more information, please visit Please see full terms of use and disclaimers on the TechMediaWire website applicable to all content provided by TMW, wherever published or re-published: /Disclaimer TechMediaWire Los Angeles, CA 310.299.1717 Office [email protected] TechMediaWire is powered by IBN MENAFN26122024000224011066ID1109033810 Legal Disclaimer: MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.
SAN DIEGO (AP) — Syracuse coach Fran Brown and Washington State acting coach Pete Kaligis shared a heartfelt hug after their Holiday Bowl news conference on Thursday. Kaligis can certainly use all the support he can get, especially an embrace and some encouraging words from the opposing coach. No. 22 Syracuse (9-3, No. 21 CFP), led by national passing leader Kyle McCord, is a 17-point favorite according to BetMGM in Friday night's Holiday Bowl against the depleted Cougars (8-4), whose season has nosedived since mid-November. After beating future Pac-12 opponent San Diego State 29-26 on Oct. 26 at Snapdragon Stadium, coach Jake Dickert, quarterback John Mateer and the rest of the Cougars were 7-1 and about to jump into The Associated Press Top 25. Now the Cougars are barely recognizable as they return to Snapdragon. Dickert was hired away by Wake Forest, Mateer transferred to Oklahoma and running back Wayshawn Parker left for Utah. Numerous coaches, including the offensive and defensive coordinators, are gone, and more than 20 players have entered the transfer portal. The Cougars, who lost their last three games, are a prime example of how college football's rapidly changing landscape can dramatically affect a program. “Going into the ins-and-outs of the game tomorrow doesn’t matter,” Kaligis said. “We are who we are, we have what we have. I know that’s for both of us.” Kaligis said players who entered the portal after Dickert left can suit up Friday night. “I know we came here with 98 guys. That's who we’re going to show up on the field with.” Kaligis said relationships between players and coaches are more important than ever, even if there's less time to develop trust “and coach them the right way.” “When a staff (member) leaves and guys get in the portal, it’s because of the relationships they have garnered with their position coaches. When that position coach isn’t guaranteed he’s going to be there, that’s who that young man trusts,” Kaligis said. “I’ve been doing this for a long time," he added. "What’s been hard for me, I spent 13 years at Wyoming, I saw three graduating classes. I remember I was the longest-tenured coach there. To see them all the way through. When I came to Wazzu, I was their fourth D-line coach." The Cougs improved to 8-1 by beating Utah State 49-28 on Nov. 9 but then lost three straight, including to Oregon State in the de facto championship game between the two teams left in the Pac-12. They also lost to New Mexico and Wyoming, two of the Mountain West teams that weren't invited to join the reconstituted Pac-12 starting in 2026. McCord, who transferred from Ohio State, rewrote the Orange's record book this season with 4,326 yards passing, 29 touchdowns and 367 completions. He's well within range of breaking Deshaun Watson's ACC single-season record of 4,593, which he set in 15 games in 2016. A win will give Syracuse 10 wins for the first time since 2018 and just the third time since 2000. Brown can become the second Syracuse coach since World War II to record 10 wins in his first season, joining Paul Pasqualoni, who did it in 1991. In their final regular-season game, the Orange rallied from a 21-0 deficit for a 42-38 win against then-No. 6 Miami that knocked the Hurricanes out of ACC title contention and ended their College Football Playoff hopes. McCord threw for 380 yards and three touchdowns. “We want to go out and have a good game,” Brown said. “We have an opportunity of winning 10 games, which means you’re starting to become a successful program, right? Our players haven’t had a chance of winning a bowl game. So there’s a lot of things that are on the line for us to really be able to build our program and being able to move forward.” This will be the teams' second meeting. Syracuse beat Washington State 52-25 in 1979. Get poll alerts and updates on the AP Top 25 throughout the season. Sign up here . AP college football: https://apnews.com/hub/ap-top-25-college-football-poll and https://apnews.com/hub/college-footballArne Slot has said Liverpool will not get carried away with being tagged title favourites given the fine margins in the Premier League and Manchester City’s track record of reeling in rivals. Liverpool opened up a five-point lead over City before the international break and have made their best start to a Premier League season since winning the title in 2019-20. Opta now gives Liverpool a 60.3% chance of winning this season’s championship but Slot, whose side visit the bottom club, Southampton, on Sunday, insists recent history shows the reigning champions can never be written off. Arsenal held an eight-point lead over City on 1 April 2023. Liverpool were three points clear of City in April of this year. Pep Guardiola’s team won the title on both occasions. “I don’t talk about favourites,” Slot said. “It is boring but I just talk about the next game, which is a challenge in itself. In the Premier League the margins are very small. That is true all season. I have followed the league and there was a moment when City were eight points behind Arsenal, so there is no use in getting carried away at all at this moment in time. “These teams like City, Arsenal and Chelsea, even [Manchester] United and all the others, are able to put together a run of games like we did. So we are not getting carried away at all and looking at it in terms of favourites. The players know what they have to do to win a game, and it’s a lot. If they could give 50% less and still win, maybe we would think we have 50% extra in the tank and not need to give our maximum for results. But we know it has been a close call in many games.” Slot concedes that Liverpool’s remarkable start – nine wins in 11 league games, 15 wins in 17 matches in all competitions – has helped eradicate any concerns the players might have had over him replacing Jürgen Klopp in the summer. “It is completely normal they thought that. They didn’t just have nine years with the former manager, they had nine successful years,” he said. “Then you always wonder, ‘Are things going to change?’ In the summer we didn’t bring in that many new players so then it is quite normal, if you look at the teams we are competition with who did bring in players, to think, ‘What is going to happen this season?’ Especially because nearly all of them were on holiday two weeks before the season started. “That is why it was really helpful we got results from the start and they saw from the start the playing style didn’t change that much. So that combination of things helped.” Sign up to Football Daily Kick off your evenings with the Guardian's take on the world of football after newsletter promotion Liverpool will be without Trent Alexander-Arnold, Alisson, Diogo Jota and Federico Chiesa at St Mary’s. Of the injured quartet, only Alexander-Arnold has not been ruled out of next week’s Champions League game against Real Madrid.
Scottie Scheffler takes Hero World Challenge, adding to historic 2024 season
The Minnesota Timberwolves delivered an impressive Christmas Day win over the Dallas Mavericks, ending a losing streak . It’s been rough lately for the Minnesota Timberwolves , with a three-game losing streak heading into their December 25 showdown with the Dallas Mavericks . The Timberwolves came out hot against the Mavs, holding off a fourth quarter comeback led by Kyrie Irving to win 105-99. Despite the win, Minnesota are only 15-14 for the season, ninth in the Western Conference , after finishing third in 2023-24. Karl-Anthony Towns trade haunts Minnesota The Minnesota Timberwolves season was set off-kilter by a trade being made just before the season kicked off, with Karl-Anthony Towns sent to the New York Knicks. The Timberwolves received Julius Randle and Donte DiVincenzo , yet despite the 2-for-1, Minnesota just are not the same team they were with Towns . Former NBA star Patrick Beverley recently ripped the move as an ‘awful trade’ , while star player Anthony Edwards has admitted the offense lacks identity . Mavs star Kyrie Irving praised the way Edwards had come out publicly to try and jolt his team on – but one former player believes the superstar must shoulder his share of the blame. Kendrick Perkins blames Anthony Edwards Speaking on the Road Trippin’ podcast, former NBA star and ESPN analyst Kendrick Perkins believes the Towns trade would not been approved without Edwards’ sign-off. And with that, he argues that rising star Edwards must take his share of the blame for their situation. He said: “I was very high on Anthony Edwards. Now, Anthony Edwards shot his own self in the foot, and here’s why. “There’s no way in hell you trade Karl-Anthony Towns to New York for Julius Randle and Donte [DiVincenzo] and whatever else they got back, without getting Anthony Edwards approval. No one can make me believe otherwise. “I’ve heard over the last month maybe two months, a lot of complaining from Anthony Edwards, whether it was lack of effort from his teammates, selfishness, offense, complaining about the officials. “Ant-man, I love you to death, you are one of my fav players in the game, you got to take some blame for this ___. This was a guy you had on your squad that you went to the Western Conference Finals last year.” How much stock you can place in Perkins comments is debatable, but it’s not uncommon for franchises to consult with players on the moves they make. Ultimately, however, the front-office have to take the most blame for the situation, while head coach Chris Finch is rightfully coming under some scrutiny . The T-Wolves’ big win on Christmas Day was a step in the right direction. Now they must do it again against the Houston Rockets, to avoid falling back to .500 for the season. This article first appeared on NBA Analysis Network and was syndicated with permission.
NoneGene Editing Market to See Rapid Expansion Over the Next Decade 2024-2032 12-14-2024 01:55 PM CET | Health & Medicine Press release from: Cognate Insights Gene Editing Market Latest Market Overview The global gene editing market is poised for substantial growth, with an estimated market size of USD 7.6 billion in 2024. This market is projected to expand at a compound annual growth rate (CAGR) of 15.4% from 2024 to 2032, reaching an estimated value of USD 26.5 billion by 2032. Gene editing technologies, such as CRISPR-Cas9, TALEN, and ZFNs, are revolutionizing the fields of biotechnology and healthcare by enabling precise modifications to DNA. The increasing demand for gene therapies, advancements in agricultural biotechnology, and the growing prevalence of genetic disorders are key factors fueling the growth of this market. The Gene Editing Market has experienced steady growth in recent years and is expected to continue expanding at a strong pace from 2024 to 2032. This analysis offers a comprehensive overview, providing valuable insights into key trends and developments within the Gene Editing industry. These findings equip business leaders with the necessary knowledge to devise more effective strategies and enhance profitability. Furthermore, the report serves as a useful resource for new and emerging businesses, helping them make informed decisions as they navigate the market and seek growth opportunities. Major Players of Gene Editing Market are: Editas Medicine (USA, Revenue: $32.5 million) Intellia Therapeutics (USA, Revenue: $44.6 million) CRISPR Therapeutics (Switzerland, Revenue: $313.3 million) Sangamo Therapeutics (USA, Revenue: $111.5 million) Beam Therapeutics (USA, Revenue: $17.9 million) Get Latest PDF Sample Report @ https://www.cognateinsights.com/request-sample/gene-editing-market-research Our Report covers global as well as regional markets and provides an in-depth analysis of the overall growth prospects of the market. Global market trend analysis including historical data, estimates to 2024, and compound annual growth rate (CAGR) forecast to 2032 is given based on qualitative and quantitative analysis of the market segments involving economic and non-economic factors. Furthermore, it reveals the comprehensive competitive landscape of the global market, the current and future market prospects of the industry, and the growth opportunities and drivers as well as challenges and constraints in emerging and emerging markets. Global Gene Editing Market Landscape and Future Pathways: North America: United States Canada Europe: Germany France U.K. Italy Russia Asia-Pacific: China Japan South Korea India Australia China Taiwan Indonesia Thailand Malaysia Latin America: Mexico Brazil Argentina Korea Colombia Middle East & Africa: Turkey Saudi Arabia UAE Korea Speak to Our Analyst for A Discussion on The Above Findings, And Ask for A Discount on The Report @ https://www.cognateinsights.com/check-discount/gene-editing-market-research Key drivers and challenges influencing the Gene Editing market: Regional Analysis: The report involves examining the Gene Editing market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets. Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Gene Editing market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends. Company Analysis: Report covers individual Gene Editing manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies. Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Gene Editing This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application. Technology Analysis: Report covers specific technologies relevant to Gene Editing. It assesses the current state, advancements, and potential future developments in Gene Editing areas. Reason to Buy this Report: -Analysis of the impact of technological advancements on the market and the emerging trends shaping the industry in the coming years. -Examination of the regulatory and policy changes affecting the market and the implications of these changes for market participants. -Overview of the competitive landscape in the Gene Editing market, including profiles of the key players, their market share, and strategies for growth. -Identification of the major challenges facing the market, such as supply chain disruptions, environmental concerns, and changing consumer preferences, and analysis of how these challenges will affect market growth. -Evaluation of the potential of new products and applications in the market, and analysis of the investment opportunities for market participants. For In-Depth Competitive Analysis - Purchase this Report now at @ https://www.cognateinsights.com/purchase-report/gene-editing-market-research Contact Us: Cognate Insights Web: www.cognateinsights.com Email: info@cognateinsights.com Phone: +91 8424946476 About Us: We are leaders in market analytics, business research, and consulting services for Fortune 500 companies, start-ups, financial & government institutions. Since we understand the criticality of data and insights, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. To be at our client's disposal whenever they need help on market research and consulting services. We also aim to be their business partners when it comes to making critical business decisions around new market entry, M&A, competitive Intelligence and strategy. This release was published on openPR.
Nearly 1 million Afghan refugees return home in eight monthsNoneFortinet Launches FortiAppSec Cloud to Strengthen Web Security
DMP chief vows action against extortion using cases
Global Medical Oxygen Concentrators Market Size: Strong Growth Ahead (2024-2032) 12-14-2024 02:00 PM CET | Health & Medicine Press release from: Cognate Insights Medical Oxygen Concentrators Market Latest Market Overview The global medical oxygen concentrators market is expected to reach USD 3.4 billion by 2024, growing at a compound annual growth rate (CAGR) of 8.1% during the forecast period from 2024 to 2032. Medical oxygen concentrators are devices used to provide oxygen therapy to patients with respiratory conditions such as chronic obstructive pulmonary disease (COPD), asthma, and COVID-19. The growing prevalence of respiratory diseases, increased awareness of home healthcare solutions, and advancements in oxygen therapy technologies are driving the demand for medical oxygen concentrators. The market is further fueled by the rising adoption of home care settings and the increasing geriatric population globally, which is more susceptible to respiratory conditions. The Global Medical Oxygen Concentrators Market has experienced steady growth in recent years and is expected to continue expanding at a strong pace from 2024 to 2032. This analysis offers a comprehensive overview, providing valuable insights into key trends and developments within the Global Medical Oxygen Concentrators industry. These findings equip business leaders with the necessary knowledge to devise more effective strategies and enhance profitability. Furthermore, the report serves as a useful resource for new and emerging businesses, helping them make informed decisions as they navigate the market and seek growth opportunities. Major Players of Global Medical Oxygen Concentrators Market are: Inogen, Inc. (California, USA) - Revenue: USD 410 million (2023) Philips Respironics (Pennsylvania, USA) - Revenue: USD 640 million (2023) Invacare Corporation (Ohio, USA) - Revenue: USD 380 million (2023) Nidek Medical Products (Alabama, USA) - Revenue: USD 250 million (2023) Chart Industries, Inc. (Georgia, USA) - Revenue: USD 420 million (2023) Get Latest PDF Sample Report @ https://www.cognateinsights.com/request-sample/global-medical-oxygen-concentrators-market-research Our Report covers global as well as regional markets and provides an in-depth analysis of the overall growth prospects of the market. Global market trend analysis including historical data, estimates to 2024, and compound annual growth rate (CAGR) forecast to 2032 is given based on qualitative and quantitative analysis of the market segments involving economic and non-economic factors. Furthermore, it reveals the comprehensive competitive landscape of the global market, the current and future market prospects of the industry, and the growth opportunities and drivers as well as challenges and constraints in emerging and emerging markets. Global Global Medical Oxygen Concentrators Market Landscape and Future Pathways: North America: United States Canada Europe: Germany France U.K. Italy Russia Asia-Pacific: China Japan South Korea India Australia China Taiwan Indonesia Thailand Malaysia Latin America: Mexico Brazil Argentina Korea Colombia Middle East & Africa: Turkey Saudi Arabia UAE Korea Speak to Our Analyst for A Discussion on The Above Findings, And Ask for A Discount on The Report @ https://www.cognateinsights.com/check-discount/global-medical-oxygen-concentrators-market-research Key drivers and challenges influencing the Global Medical Oxygen Concentrators market: Regional Analysis: The report involves examining the Global Medical Oxygen Concentrators market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets. Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Global Medical Oxygen Concentrators market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends. Company Analysis: Report covers individual Global Medical Oxygen Concentrators manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies. Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Global Medical Oxygen Concentrators This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application. Technology Analysis: Report covers specific technologies relevant to Global Medical Oxygen Concentrators. It assesses the current state, advancements, and potential future developments in Global Medical Oxygen Concentrators areas. Reason to Buy this Report: -Analysis of the impact of technological advancements on the market and the emerging trends shaping the industry in the coming years. -Examination of the regulatory and policy changes affecting the market and the implications of these changes for market participants. -Overview of the competitive landscape in the Global Medical Oxygen Concentrators market, including profiles of the key players, their market share, and strategies for growth. -Identification of the major challenges facing the market, such as supply chain disruptions, environmental concerns, and changing consumer preferences, and analysis of how these challenges will affect market growth. -Evaluation of the potential of new products and applications in the market, and analysis of the investment opportunities for market participants. For In-Depth Competitive Analysis - Purchase this Report now at @ https://www.cognateinsights.com/purchase-report/global-medical-oxygen-concentrators-market-research Contact Us: Cognate Insights Web: www.cognateinsights.com Email: info@cognateinsights.com Phone: +91 8424946476 About Us: We are leaders in market analytics, business research, and consulting services for Fortune 500 companies, start-ups, financial & government institutions. Since we understand the criticality of data and insights, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. To be at our client's disposal whenever they need help on market research and consulting services. We also aim to be their business partners when it comes to making critical business decisions around new market entry, M&A, competitive Intelligence and strategy. This release was published on openPR.Trump says he can't guarantee tariffs won't raise US prices and won't rule out revenge prosecutions
10 Industrials Stocks With Whale Alerts In Today's SessionAs science continues its evolution, discoveries and technologies can act like a master key that open doors leading to novel advancements. Artificial intelligence is one such key, making innovations possible by solving complex problems, automating tasks and enabling research that would have been impossible, or very time-consuming, without it. Mohammad Hosseini But do we want to do research on all topics, and shall we try the AI master key on every door? To explore this question, let’s consider the use of AI by genomics experts as an example. In recent years, genomics experts have added unbelievable depth to what we know about the world and ourselves. For example, genetics researchers have revealed facts about when certain animals and plants were domesticated. In another example, researchers used DNA from 30,000-year-old permafrost to create fertile samples of a plant called narrow-leafed campion. Importantly, genetic engineering has facilitated extraordinary advances in the treatment of complicated conditions, such as sickle-cell anemia. Thanks to AI, we are witnessing a dramatic increase in the pace and scalability of genomic exploration. But given the risks and possible consequences of AI use in science, should we rush headlong into using AI in all kinds of projects? One relevant example is research on Neanderthals, our closest relatives, who lived about 40,000 years ago. Neanderthals have been studied for several years now through genetic investigation of their fossils and their DNA. Genetic engineering can potentially use ancient DNA and genome editing methods to re-create a Neanderthal or aspects of a Neanderthal’s genetics and physiology. To do this, scientists could start by figuring out the DNA sequence of a Neanderthal by comparing it with the DNA of modern humans, because they are closely related. Then, scientists could use the gene-editing tool known as CRISPR to swap out parts of human DNA with Neanderthal DNA. This process would require a lot of trial and error and might not succeed soon. But based on what we know about genetics, if something is possible, AI can help make it happen faster, cheaper and with less effort. Scientists are excited about these developments because they could facilitate new discoveries and open up many research opportunities in genetic research. With or without AI, research on Neanderthals will proceed. But the extraordinary power of AI could give the final push to these discoveries and facilitate this kind of resurrection. At that point, the scientific community must develop norms and guidelines about how to treat these resurrected beings with dispositions very similar to humans. We would need to carefully consider their rights and well-being almost in the same way as when humans are involved and not as research subjects or artifacts of scientific curiosity. These ethical issues are discussed in more detail in a new paper published in the journal Nature Machine Intelligence. A more holistic question to consider is: Should we prioritize the use of resource-intensive AI, researchers’ time and public funds to resurrect extinct beings? Or should we invest these resources into conserving species that are critically endangered today to prevent biodiversity from more degradation? Hosseini is an assistant professor in the Department of Preventive Medicine at Northwestern University’s Feinberg School of Medicine. He wrote this for The Chicago Tribune . Get opinion pieces, letters and editorials sent directly to your inbox weekly!ATLANTA — On Jan. 18 and 19 the AT&T Playoff Playlist Live! will be held at State Farm Arena in advance of the College Football Playoff national championship on Jan. 20. The star-studded lineup was announced Thursday at a news conference at Mercedes-Benz Stadium. Performances will include Lil Wayne and GloRilla on Saturday; and Camila Cabello, Myles Smith and Knox on Sunday. On game day, the Allstate Championship Tailgate, taking place just outside Mercedes-Benz Stadium in the Home Depot Backyard, will feature country acts on the Capital One Music Stage, including global superstar Kane Brown and iHeartCountry “On The Verge” artist Ashley Cooke. The concerts are just two of the festivities visiting fans can enjoy in the days leading up to the big game. The fan experience for both ticket holders and the general public has been a focus for event planners. All weekend long, an estimated 100,000 people from across the country are expected to attend fan events preceding kickoff. “It will be an opportunity for fans of all ages to come together to sample what college football is all about, and you don’t have to have a ticket to the game to be a part of it,” said Bill Hancock, executive director of the CFP in a press release. “We’ve worked closely with the Atlanta Football Host Committee to develop fan-friendly events that thousands will enjoy come January.” On Saturday, Jan. 18, Playoff Fan Central will open at the Georgia World Congress Center in downtown Atlanta. The free, family-friendly experience will include games, clinics, pep rallies, special guest appearances, autograph signings and exhibits celebrating college football and its history. That day, fans can also attend Media Day, presented by Great Clips, which will feature one-hour sessions with student-athletes and coaches from each of the College Football Playoff national championship participating teams. ESPN and social media giants X, Facebook, Instagram and TikTok will be taping live broadcasts from the event. On Sunday, Jan. 19, the Trophy Trot, both a 5K and 10K race, will wind its way through the streets of downtown Atlanta. Each Trophy Trot participant will receive a T-shirt and finisher’s medal. Participants can register at . On Sunday evening, the Georgia Aquarium will host the Taste of the Championship dining event, which offers attendees the opportunity to indulge in food and drink prepared by local Atlanta chefs. This premium experience serves as an elevated exploration of local cuisine on the eve of the national championship. Tickets to the Taste of the Championship event are available on . Atlanta is the first city ever to repeat as host for the CFP national championship. The playoff was previously held in Atlanta in 2018. “We are honored to be the first city to repeat as host for the CFP national championship and look forward to welcoming college football fans from around the country in January,” said Dan Corso, president of the Atlanta Sports Council and Atlanta Football Host Committee. “This event gives us another opportunity to showcase our incredible city.” The College Football Playoff is the event that crowns the national champion in college football. The quarterfinals and semifinals rotate annually among six bowl games — the Goodyear Cotton Bowl Classic, Vrbo Fiesta Bowl, Capital One Orange Bowl, Chick-fil-A Peach Bowl, Rose Bowl Game presented by Prudential and the Allstate Sugar Bowl. This year’s quarterfinals will take place on Dec. 31, 2024 and Jan. 1, 2025, while the semifinals will be Jan. 9-10, 2025. The CFP national championship will be Monday, Jan. 20, 2025, at Mercedes-Benz Stadium. For additional information on the College Football Playoff, visit .
Cornerback Sauce Gardner (hamstring), right tackle Morgan Moses (knee) and right guard Alijah Vera-Tucker (ankle) also were sidelined for the Jets' first full practice of the week. Quarterback Aaron Rodgers, who acknowledged Tuesday he's dealing with “a little MCL” issue in a knee but said “there's no way I'm not playing,” practiced fully. Adams was apparently injured in New York's 19-9 loss to the Los Angeles Rams last Sunday, when he had seven catches for 68 yards and a touchdown. Adams, acquired from Las Vegas in October, has 56 receptions for 719 yards and six touchdowns on 94 targets in nine games for the Jets. He's 72 yards away from his fifth straight 1,000-yard season and sixth of his career. Adams and Rodgers are also tied with Miami's Dan Marino and Mark Clayton for the third-most TD connections (82), including playoffs, by a quarterback-wide receiver duo. Gardner sat out the second half of the loss to the Rams with the hamstring injury and could miss the game against the Bills. He sat out one game after injuring a hamstring against Seattle in Week 14. It's unclear if the injuries are related. Moses and Vera-Tucker have been playing through their ailments the past several weeks. Defensive lineman Quinnen Williams, who missed the game last Sunday with a hamstring injury, was limited Thursday at practice, as were left guard John Simpson (calf), defensive end Haason Reddick (neck), safety Tony Adams (ankle), conerback Michael Carter II (back) and rookie defensive lineman Braiden McGregor (ankle). AP NFL: https://apnews.com/hub/NFL
Top 10 Best Freight Forwarding Companies in India 2025Two dead after being hit by sail boom in Sydney to Hobart Yacht Race